Browsing Wolfson Institute of Preventive Medicine by Author "Williams-Gray, CH"
Now showing items 1-7 of 7
-
Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
Mok, KY; Sheerin, U; Simón-Sánchez, J; Salaka, A; Chester, L; Escott-Price, V; Mantripragada, K; Doherty, KM; Noyce, AJ; Mencacci, NE (2016-05) -
Differences in the presentation and progression of Parkinson's disease by sex
Iwaki, H; Blauwendraat, C; Leonard, HL; Makarious, MB; Kim, JJ; Liu, G; Maple-Grødem, J; Corvol, J-C; Pihlstrøm, L; van Nimwegen, M (2020-04-11) -
Differences in the Presentation and Progression of Parkinson's Disease by Sex
Iwaki, H; Blauwendraat, C; Leonard, HL; Makarious, MB; Kim, JJ; Liu, G; Maple-Grodem, J; Corvol, J-C; Pihlstrom, L; van Nimwegen, M (Wiley, 2020-10-01) -
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Gonzalez-Robles, C; Bartlett, M; Burnell, M; Clarke, CS; Haar, S; Hu, MT; Huxford, B; Jha, A; Lawton, M; Noyce, A (2023-12-22)BACKGROUND: Clinical trials of disease-modifying therapies in PD require valid and responsive primary outcome measures that are relevant to patients. OBJECTIVES: The objective is to select a patient-centered primary outcome ... -
Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts
Iwaki, H; Blauwendraat, C; Leonard, HL; Liu, G; Maple-Grødem, J; Corvol, JC; Pihlstrøm, L; Van Nimwegen, M; Hutten, SJ; Nguyen, KDH (2019-08-01)Copyright © 2019 The Author(s). Objective To determine if any association between previously identified alleles that confer risk for Parkinson disease and variables measuring disease progression. Methods We evaluated the ... -
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
Iwaki, H; Blauwendraat, C; Leonard, HL; Kim, JJ; Liu, G; Maple-Grødem, J; Corvol, J-C; Pihlstrøm, L; van Nimwegen, M; Hutten, SJ (2019-12)BACKGROUND: Several reports have identified different patterns of Parkinson's disease progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall contribution of genetic factors to the severity ... -
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial Initiative
Gonzalez-Robles, C; Weil, RS; van Wamelen, D; Bartlett, M; Burnell, M; Clarke, CS; Hu, MT; Huxford, B; Jha, A; Lambert, C (2023)